Navigation Links
Study Shows Brain Fitness can Save Medicare Billions
Date:8/4/2009

SAN FRANCISCO, Aug. 4 /PRNewswire/ -- Just ten hours of the right brain fitness exercises can have a significant and long lasting impact on healthcare costs and outcomes, according to a study recently published in BMC Health Services Research, a leading peer-reviewed health services journal.

Researchers found that participants who did just ten hours of special computerized brain exercises had better health outcomes, lowering projected Medicare costs by hundreds of dollars per year. As the number of Medicare enrollees grows from 44 million to 61 million over the next ten years, this represents more than $100 billion in potential savings.

The report is part of a multi-site trial funded by the National Institutes of Health and known as the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study. There were 2,802 healthy adults, aged 65 and older, enrolled in the study. The participants were divided into three intervention groups and a no contact control group. The intervention groups received classroom training in reasoning or memory strategies or took part in computerized brain fitness exercises. Each intervention was based on a total of ten hours of training over one initial six-week period. Participants have been followed for more than five years.

The ACTIVE study team previously reported that participants who performed the computerized brain exercises had significantly improved health outcomes, as measured by a widely used instrument assessing health-related quality of life, known as the SF-36. In this report, researchers used a model recently developed by the federal Agency for Healthcare Research and Quality (AHRQ) to predict healthcare costs, based on massive correlation of actual healthcare costs to SF-36 scores.

The researchers found that a yea
'/>"/>

SOURCE Posit Science
Copyright©2009 PR Newswire.
All rights reserved

7

GOOD

Page: 1 2 3

Related medicine technology :

1. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
2. OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
3. Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
4. Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
5. Cyberonics Provides Update on Depression Post-Approval Study
6. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
7. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
8. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
9. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
10. Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
11. Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... Planning for Phase 3 Trial Initiation on Track ... Limited (ASX: PGL; Nasdaq: PGLA) today announced it ... Contract Research,Organisation, to utilise their services for a ... the execution of the,Phase 3 clinical trial of ...
... Topic of Drug Repurposing and ... Indian Clinical Trial Strategy, ... biopharmaceutical company, announced today,that Chief Executive Officer, John Maki, and ... 234th American Chemical,Society National Meeting on Sunday, August 19, 2007. ...
Other Medicine Technology:Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 2Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 3Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 2Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 3
(Date:5/23/2012)... Reporter , , TUESDAY, May 22 (HealthDay News) -- ... procedure, which involves threading a camera through the ... But a new study has found that patients ... less time-consuming CT-based colon scan. Colonoscopy ... colon cancer screening. Computed tomography (CT) colonography -- ...
(Date:5/23/2012)... The number of viral infections during infancy is not ... new study from researchers in the Netherlands. While viral ... childhood, this association was due in part to decreased ... particularly rhinovirus, are thought to be a risk factor ... this association is due to the viruses themselves or ...
(Date:5/23/2012)... A tiny, resilient metal wire designed to gather ... patients with severe heterogeneous emphysema, a subtype of the ... lungs, according to the results of a multicenter international ... wire, called a lung volume reduction coil (LVRC), can ... place of more invasive procedures used to improve the ...
(Date:5/23/2012)... present findings on prostate cancer risk, screening, treatment ... of the American Urological Association May 19-23 in ... to provide expert comment for reporters covering the ... presented and their embargo dates include: , ... surgery hormone therapy , Embargoed until 10:30 a.m. ...
(Date:5/22/2012)... OR Bend Research Inc., a leading ... the expansion of its existing hot-melt extrusion ... 18mm Leistritz twin-screw mixer/extruder. , The ... existing 27mm Leistritz and 19mm Baker Perkins ... continuous high-shear wet-granulation capabilities. Many projects have ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4
... A well-informed consumer will be a healthy one, too ... prescription filled is such a routine task, most people ... potentially a big mistake, according to medical experts -- ... cases, do real harm. , Pharmacists and health-care advocates ...
... to the Marketing Messages for Advair,and Xolair, According ... WALTHAM, Mass., Nov. 5 Decision Resources one ... on pharmaceutical and,healthcare issues, finds that physicians and ... asthma medicine to use.,Physicians indicate that brands conveying ...
... 9:00 a.m. EST -, VALENCIA, Calif., Nov. 5 ... results for the third quarter ended,September 30, 2008., ... were $69.1,million, compared to $75.6 million for the third ... in research and development,(R&D) expenses which totaled $55.6 million ...
... Stay Balanced Through the ... ... and New York Times best-selling author Ellie Krieger, of Food Network,fame, ... health. Yo-Plus contains live and active probiotic cultures,specifically designed for digestive ...
... CARY, N.C., Nov. 5 Cornerstone Therapeutics,Inc. ... focused on,developing and commercializing prescription medications for ... terms of the recently,completed merger between Cornerstone ... A. Collard, 42, president and chief executive,officer ...
... Inc. announced that,it reached a new high of more than ... case during the third quarter of 2008.,In addition, the quarter ... case activity with a leap of 64 %. Revenue and ... Through nine months of 2008,CardiacAssist has also set records in ...
Other Medicine News:Health News:When It Comes to Prescription Drugs, Get Smart 2Health News:When It Comes to Prescription Drugs, Get Smart 3Health News:Physicians Rank Schering-Plough's Marketing Messages for Asmanex as the Most Appealing in the Asthma Drug Market 2Health News:MannKind Corporation Reports Third Quarter Financial Results 2Health News:MannKind Corporation Reports Third Quarter Financial Results 3Health News:MannKind Corporation Reports Third Quarter Financial Results 4Health News:MannKind Corporation Reports Third Quarter Financial Results 5Health News:MannKind Corporation Reports Third Quarter Financial Results 6Health News:MannKind Corporation Reports Third Quarter Financial Results 7Health News:MannKind Corporation Reports Third Quarter Financial Results 8Health News:Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health 2Health News:Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health 3Health News:Cornerstone Therapeutics Announces New Board of Directors 2Health News:Cornerstone Therapeutics Announces New Board of Directors 3Health News:Cornerstone Therapeutics Announces New Board of Directors 4Health News:Cornerstone Therapeutics Announces New Board of Directors 5Health News:CardiacAssist, Inc. Announces Record Breaking Site Activity and Financial Results 2
... the revolutionary OxiMax® Pulse Oximetry System, ... Nellcor's best-in-class pulse oximetry with the ... OxiMax N-595 Pulse Oximeter is equipped ... technology, which enables it to withstand ...
The Model 340 is intended for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
A pocket-sized pulse oximeter. Perfect for the physician's office, emergency medicine, hospitals and clinics, and home health care....
... The Autocorr Pulse Oximeter with SAC ... unique patented software to extract SpO 2 ... in a new way. This cost-effective ... study functions as standard features, and a ...
Medicine Products: